Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Consumer Cyclical Companies: TJX Companies (TJX) and Tesla (TSLA)

Tipranks - Sat Apr 4, 11:46AM CDT

Analysts have been eager to weigh in on the Consumer Cyclical sector with new ratings on TJX Companies (TJX) and Tesla (TSLA).

End of Quarter Sale - 50% Off TipRanks

TJX Companies (TJX)

In a report released yesterday, Hans Engel from Erste Group maintained a Buy rating on TJX Companies. The company’s shares closed last Thursday at $161.29.

According to TipRanks.com, Engel is a 4-star analyst with an average return of 8.5% and a 53.7% success rate. Engel covers the Healthcare sector, focusing on stocks such as Vertex Pharmaceuticals, Boston Scientific, and Johnson & Johnson. ;'>

The word on The Street in general, suggests a Strong Buy analyst consensus rating for TJX Companies with a $177.00 average price target, a 9.6% upside from current levels. In a report issued on March 26, Bernstein also maintained a Buy rating on the stock with a $175.00 price target.

See today’s best-performing stocks on TipRanks >>

Tesla (TSLA)

In a report released yesterday, Gordon Johnson from GLJ Research reiterated a Sell rating on Tesla, with a price target of $25.28. The company’s shares closed last Thursday at $360.59.

According to TipRanks.com, Johnson is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -5.8% and a 54.8% success rate. Johnson covers the Technology sector, focusing on stocks such as Daqo New Energy, Enphase Energy, and Nextpower Inc. ;'>

The word on The Street in general, suggests a Hold analyst consensus rating for Tesla with a $394.36 average price target, which is an 8.3% upside from current levels. In a report issued on March 19, UBS also maintained a Sell rating on the stock with a $352.00 price target.

Read More on TJX:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.